Allogene Therapeutics Inc at Bank of America Healthcare Conference Transcript
Thanks for joining us this morning at the Bank of America Annual Healthcare Conference in Las Vegas. I am Jason Gerberry. I'm one of the biotech analysts at BofA. And I am pleased to be introducing our next -- our first company presenter, Allogene Therapeutics and Eric Schmidt, CFO.
Eric, I think, has a couple of prepared remarks, and then we'll go right into Q&A from there.
Thank you, Jason. Thanks for the invitation. Thanks to Bank of America for hosting myself and our Chief Commercial Officer, Christine Cassiano, who's here in the front row. And thanks, everyone, for getting up early to kick off this conference. I appreciate those on the webcast as well.
In terms of a quick background on Allogene, Matthew, we have just one slide I'd like to present for those a little less familiar to our story. We're a 4-year-old company. In fact, we celebrated our fourth anniversary just earlier this year. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
